Latest News- Preclinical Isolated Organ Perfusion System Market: Industrial laboratories and CROs is expected to lead the End-user segment during 2025-2029

The Preclinical Isolated Organ Perfusion System Market is being driven by Increasing prevalence of chronic diseases

The Preclinical Isolated Organ Perfusion System Market is expected to grow at a CAGR of 4.6% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 150.8 million. The global health landscape is witnessing a significant increase in the prevalence of various diseases, such as cardiovascular conditions, metabolic disorders, and cancer. This trend has spurred a surge in preclinical and clinical research activities within the pharmaceutical industry and Contract Research Organizations (CROs). The adoption of advanced omics-based technologies, including genomics, proteomics, and metabolomics, has become increasingly popular in the development of innovative therapeutic candidates. Consequently, numerous public and private funding organizations have invested substantially in drug development and research projects worldwide. This growing investment in pharmaceutical research and testing has resulted in the introduction of a multitude of new drug candidates and biosimilars into the market. 

Get more information on Preclinical Isolated Organ Perfusion System Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• End-user
  • Industrial laboratories and CROs
  • Academic and government research institutes
• Type
  • Isolated heart perfusion systems
  • Isolated abdominal organ perfusion systems
  • Isolated lung perfusion systems
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
    • South Korea
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of chronic diseases
• Growing demand for organ transplantation
• Rising awareness about isolated organ research

However, the market also witnesses some limitations, which are as follows:

• High cost of isolated organ perfusion systems
• Ethical concerns over use of animals in research
• Shortage of skilled technicians regarding isolated organ perfusion system

Benefits of Buying Global Preclinical Isolated Organ Perfusion System Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Preclinical Isolated Organ Perfusion System Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Preclinical Isolated Organ Perfusion System market encompasses technologies and equipment used for the preservation and function assessment of organs, including the lung, kidney, brain, and heart, through techniques like Isolated Organ Perfusion. Applications include chemotherapy, organ transplantation, and research in cardiovascular diseases such as stroke, disability, and coronary artery disease. The market caters to both public and private healthcare sectors, offering solutions like cardiopulmonary perfusion systems, cell perfusion systems, heart-lung machines, perfusion pumps, oxygenators, monitoring systems, cannulas, and hypothermic and normothermic machine perfusion systems for drugs, healthcare products, organ donation, cell-based research, and biologics manufacturing.

Market Research Overview

The Preclinical Isolated Organ Perfusion System market is a segment of the larger Life Science Tools and Services industry. This sector encompasses organizations involved in the research and development (R&D) of various product categories, including capital equipment, instruments, accessories, and consumables. These tools are utilized for the advancement of pharmaceuticals, biotechnology products, and laboratory diagnosis of diseases. The market size is determined by the consolidated revenue generated from the sales of equipment, supplies, pharmaceuticals, biotechnology, and life science services. Factors driving growth in this sector include the increasing global population aging, with a predicted rise in individuals over 60 years, leading to a greater demand for healthcare solutions. Additionally, the market will be propelled by advancements in organ perfusion technology for organs such as the lung, kidney, and brain, as well as the application of this technology in chemotherapy and organ transplantation processes.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/